Table 1 Demographic characteristics of patients
| Â | Genomic development dataset | Genomic testing dataset | Radiogenomic dataset | Image testing dataset 1 | Image testing dataset 2 |
|---|---|---|---|---|---|
n | 200 | 559 | 236 | 537 | 69 |
Sex (%) | |||||
 F | 98 (49) | 251 (44.9) | 101 (42.8) | 225 (41.9) | 39 (56.5) |
 M | 102 (51) | 308 (55.1) | 135 (57.2) | 312 (58.1) | 30 (43.5) |
Tumour grade (%) | |||||
 High | 16 (8) | – | 53 (22.5) | 102 (19.0) | – |
 Low | 29 (14.5) | – | 17 (7.2) | 30 (5.6) | 57 (82.6) |
 Middle | 155 (77.5) | – | 135 (57.2) | 167 (31.0) | 12 (17.4) |
 Unknown | – | – | 31 (13.1) | 239 (44.4) | – |
CEA (%) | |||||
 Abnormal | – | – | 131 (55.5) | 226 (41.6) | 43 (62.3) |
 Normal | – | – | 98 (41.5) | 114 (21.0) | 26 (37.7) |
 Unknown | – | – | 7 (3.0) | 203 (37.4) | – |
TNM stage (%) | |||||
 I | 28 (14) | 32 (5.7) | 22 (9.3) | 84 (15.6) | – |
 II | 70 (35) | 262 (46.9) | 65 (27.5) | 188 (34.9) | 12 (17.4) |
 III | 75 (37.5) | 202 (36.2) | 64 (27.1) | 187 (34.8) | 41 (59.4) |
 IV | 27 (13.5) | 60 (10.7) | 82 (34.7) | 79 (14.7) | 16 (23.2) |
 Unknown | – | 3 (0.5) | 3 (1.3) | – | – |
DFS (months, mean (SD)) | 42.28(30.10) | 48.74(40.38) | 37.46 (26.70) | 56.76 (35.17) | 16.46 (4.26) |
Event (%) | |||||
 Disease-free | 145 (72.5) | 379 (67.8) | 157 (66.5) | 349 (65.0) | 41 (59.4) |
 Relapse | 55 (27.5) | 177 (31.7) | 79 (33.5) | 188 (35.0) | 28 (40.6) |
 Unknown | – | 3 (0.5) | – | – | – |